Published by Josh White on 9th July 2021
(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the results of the interim safety and futility assessment readout of the first 100 patients treated in the 'STAR' Covid-19 trial of its lead asset, 'SFX-01', on Friday.
URL: http://www.digitallook.com/dl/news/story/31976772/...